Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Chemosphere|January 28, 2017
In vitro cytotoxic effects of DEHP-alternative plasticizers and their primary metabolites on a L929 cell lineTeuta Eljezi, Pierre Pinta, Damien Richard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 8, 2008
Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agentDelphine Denoyer, Pierre Labarre, Janine Papon, et al.
Investigational New Drugs|September 19, 2020
Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcomaElise Maubert, Valérie Weber, Aurélien Voissière, et al.
Oncotarget|December 10, 2017
Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-conceptAurélien Voissiere, Valérie Weber, Yvain Gerard, et al.
Translational Oncology|August 18, 2019
Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like MechanismsHussein Akil, Jacques Rouanet, Claire Viallard, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2008
Design, synthesis, and biological activities of conformationally restricted analogs of primaquine with a 1,10-phenanthroline frameworkCheikh Sall, Ange-Désiré Yapi, Nicolas Desbois, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracerElisabeth Miot-Noirault, François Gouin, Aurélien Vidal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2011
First ex vivo study demonstrating that 99mTc-NTP 15-5 radiotracer binds to human articular cartilageFlorent Cachin, Stéphane Boisgard, Aurélien Vidal, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
The use of [(125)I] scintigraphic in vivo imaging in melanoma-bearing mice for a rapid prescreening of vectors to melanoma tissueElisabeth Miot-Noirault, Janine Papon, Marilyne Gardette, et al.
EJNMMI Research|January 8, 2020
[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancerElodie Jouberton, Sébastien Schmitt, Emmanuel Chautard, et al.
Pageof 9